The latest price target for Prothena Corp (NASDAQ:PRTA) was reported by HC Wainwright & Co. on December 20, 2024. The analyst firm set a price target for $48.00 expecting PRTA to rise to within 12 months (a possible 248.58% upside). 20 analyst firms have reported ratings in the last year.

The latest analyst rating for Prothena Corp (NASDAQ:PRTA) was provided by HC Wainwright & Co., and Prothena Corp reiterated their buy rating.

The last upgrade for Prothena Corp PLC happened on September 28, 2022 when B of A Securities raised their price target to N/A. B of A Securities previously had a neutral for Prothena Corp PLC.

The last downgrade for Prothena Corp PLC happened on January 30, 2024 when B of A Securities changed their price target from $68 to $38 for Prothena Corp PLC.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Prothena Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Prothena Corp was filed on December 20, 2024 so you should expect the next rating to be made available sometime around December 20, 2025.

While ratings are subjective and will change, the latest Prothena Corp (PRTA) rating was a reiterated with a price target of $84.00 to $48.00. The current price Prothena Corp (PRTA) is trading at is $13.77, which is out of the analyst’s predicted range.